Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Total Current Liabilities: 2016-2020

Historic Total Current Liabilities for Monopar Therapeutics (MNPR) over the last 3 years, with Sep 2020 value amounting to $609,840.

  • Monopar Therapeutics' Total Current Liabilities rose 26.09% to $609,840 in Q3 2020 from the same period last year, while for Sep 2020 it was $609,840, marking a year-over-year increase of 26.09%. This contributed to the annual value of $724,165 for FY2019, which is 81.24% up from last year.
  • Latest data reveals that Monopar Therapeutics reported Total Current Liabilities of $609,840 as of Q3 2020, which was up 6.41% from $573,127 recorded in Q2 2020.
  • In the past 5 years, Monopar Therapeutics' Total Current Liabilities ranged from a high of $724,165 in Q4 2019 and a low of $64,510 during Q4 2016.
  • Its 3-year average for Total Current Liabilities is $473,425, with a median of $468,272 in 2019.
  • Per our database at Business Quant, Monopar Therapeutics' Total Current Liabilities spiked by 383.44% in 2017 and then fell by 23.53% in 2020.
  • Monopar Therapeutics' Total Current Liabilities (Quarterly) stood at $64,510 in 2016, then surged by 383.44% to $311,867 in 2017, then increased by 28.12% to $399,551 in 2018, then soared by 81.24% to $724,165 in 2019, then grew by 26.09% to $609,840 in 2020.
  • Its last three reported values are $609,840 in Q3 2020, $573,127 for Q2 2020, and $443,520 during Q1 2020.